Scientific Committees

ASGCT's Scientific Committees are responsible for developing scientific symposia sessions presented at the Annual Meeting. The format of these sessions is determined through the guidance of the Program Committee co-chairs.

Volunteer for a Scientific Committee

Influence the very core of the ASGCT Annual Meeting by self-nominating or recommending another member for inclusion on ASGCT's scientific committees. 

Active Committees

Cancer Cell and Gene Therapy Committee

Develops scientific symposia for the ASGCT Annual Meeting in the field of cancer-related advancements in cell and gene therapy

Cardiovascular Cell and Gene Therapy Committee

Develops Annual Meeting symposia related to cardiovascular developments in cell and gene therapy.

Cell and Gene Therapy of Genetic and Metabolic Diseases

Creates Annual Meeting program profiling the advancement of cell and geen therapy in the areas of genetic and metabolic diseases.

Genome Editing Committee

Responsible for Annual Meeting scientific symposia related to genome editing.

Hematologic and Immunologic Cell and Gene Therapy

Develops Annual Meeting programming related to hematologic and immunologic cell and gene therapy.

Immune Responses to Cell and Gene Therapy

Responsible for scientific symposia focused on immune responses to cell and gene therapy.

Infectious Diseases and Vaccines Committee

Develops Annual Meeting scientific symposia focused on infectious diseases and vaccines in relation to cell and gene therapy.

Musculo-Skeletal Cell and Gene Therapy

Develops scientific symposia for the Annual Meeting highlighting cell and gene therapy for musculo-skeletal disorders.

Nanoagents & Synthetic Formulations Committee

Develops Annual Meeting programming related to nanoagents and synthetic formulations.

Neurologic & Ophthalmic Cell and Gene Therapy

Creates Annual Meeting symposia on cell and gene therapy for neurologic and opthalmic disorders.

Nonviral Therapeutic Delivery

Creates Annual Meeting scientific symposia related to physical delivery, therapeutics, and vector development.

Oligonucleotide and RNAi Therapeutics

Responsible for creating Annual Meeting scientific symposia on oligonucleotide and RNAi therapeutics.

Prenatal Gene and Cell Therapy Committee

Develops an Annual Meeting symposium and other sessions highlighting the advancements of CGT and related approaches to treat genetic diseases prior to birth. 

Respiratory & GI Tract Cell and Gene Therapy Committee

Responsible for the creation of Annual Meeting programming on cell and gene therapy for respiratory and GI tract disorders.

Stem Cell Committee

Develops scientific symposia for the Annual Meeting focused on advancements in stem cell technology.

Translational Science Committee

The Translational Science Committee is responsible for addressing matters pertaining to translational science, such as vector development, manufacturing technologies, and early clinical development. The duties of the committee include recommending educational programming relevant to translational science.

Viral Gene Transfer Vectors Committee

Develops Annual Meeting scientific symposia focused on the transfer of therapeutic genetic materials through viral vectors.

Standing Committees

Check out ASGCT's standing committees, which direct programming and initiatives outside the Annual Meeting.

2025

Class Considerations on Immunogenicity for AAV GT Products

January 22-23, 2025 | Virtual

This site uses cookies to offer you a better user experience and to analyze site traffic. By continuing to use this website, you accept our use of cookies.